Navigation Links
HistoRx Recognized as a 2010 Company to Watch by the Connecticut Technology Council

BRANFORD, Conn., Oct. 4 /PRNewswire/ -- HistoRx was recognized as a 2010 Company to Watch by the Connecticut Technology Council at the Innovation Pipeline Awards ceremony last week in New Haven, Connecticut.  HistoRx was recognized for significant milestones achieved in 2010:

  • launching its proprietary AQUA® technology software on a second hardware platform -- the ScanScope FL from Aperio
  • signing a licensing deal with a national oncology reference lab for AQUA technology and several diagnostic assays based on it -- Genoptix Medical Laboratory (Nasdaq: GXDX)
  • receiving a U.S. patent for an application of AQUA technology to personalized medicine -- methods for determining a cancer patient's prognosis based on sub-cellular localization of biomarkers, specifically thymidylate synthase (TS)

These achievements represent key indicators of the company's maturation from a life science technology company to a diagnostics developer nearing first clinical use of its products.

The Innovation & Entrepreneurship Summit is a juried event designed to showcase the products and services from approximately 100 exciting early stage companies in various advanced technology categories.  Each year the event draws several hundred investors, corporate business development executives, prospective customers and the media.  This multifaceted event included a technology showcase of the award-winning Companies to Watch, and focused on young, emerging technology companies with an innovative product or service and the potential to grow quickly.

The Connecticut Technology Council is a statewide association of technology oriented companies and institutions, providing leadership in areas of policy advocacy, community building and assistance for growing companies.  Speaking for over 2,000 companies that employ some 200,000 residents, the Connecticut Technology Council seeks to provide a strong and urgent voice in support of the creation of a culture of innovation.

HistoRx, Inc. is a leading developer of tissue-based theranostic solutions to advance individualized patient care.  The Company's products and services are based on proprietary AQUA® technology for tissue biomarker analysis.  AQUA® software is the only platform capable of precisely measuring protein biomarker concentration with sub-cellular resolution in tissue sections, enabling fully objective, standardized, reproducible, and automated analysis to guide targeted drug development and therapeutic decision making.  HistoRx currently helps biopharmaceutical companies advance their product pipelines by generating valuable new insights into the safety and effectiveness of targeted therapeutics in development for cancer and other diseases, and is developing clinical assays based on these insights.  The first clinical diagnostics based on AQUA® technology will be launched in late 2010.  For more information please visit:

SOURCE HistoRx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
2. FreshFx Recognized for use in the Scalder as a Solution to the Yield/Pathogen Reduction Dilemma
3. Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09
4. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
5. Roche Scientist Recognized for Excellence in Peptide Chemistry
6. SEI Defined Benefit Client Recognized With Leading Plan Design Award
7. Nonin Medical Recognized for Influential Contributions in Medical Technology
8. China Sky One Medical, Inc.s AMI Diagnostic Kit Recognized as a National Innovation Project by NDRC
9. AQUA(R) Technology Recognized as Promising New Strategy for Hormone Receptor Testing in Breast Cancer by NCCN Task Force
10. Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
11. Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership
Post Your Comments:
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):